首页> 外文期刊>Science >Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
【24h】

Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate

机译:1-磷酸鞘氨醇对核中组蛋白乙酰化的调节

获取原文
获取原文并翻译 | 示例
           

摘要

The pleiotropic lipid mediator sphingosine-1-phosphate (SIP) can act intracellularly independently of its cell surface receptors through unknown mechanisms. Sphingosine kinase 2 (SphK2), one of the isoenzymes that generates SIP, was associated with histone H3 and produced SIP that regulated histone acetylation. SIP specifically bound to the histone deacetylases HDAC1 and HDAC2 and inhibited their enzymatic activity, preventing the removal of acetyl groups from lysine residues within histone tails. SphK2 associated with HDAC1 and HDAC2 in repressor complexes and was selectively enriched at the promoters of the genes encoding the cyclin-dependent kinase inhibitor p21 or the transcriptional regulator c-fos, where it enhanced local histone H3 acetylation and transcription. Thus, HDACs are direct intracellular targets of SIP and link nuclear SIP to epigenetic regulation of gene expression.
机译:多效脂质介体鞘氨醇-1-磷酸(SIP)可以通过未知机制独立于其细胞表面受体在细胞内发挥作用。鞘氨醇激酶2(SphK2)是产生SIP的同工酶之一,它与组蛋白H3相关并产生调节组蛋白乙酰化的SIP。 SIP与组蛋白脱乙酰基酶HDAC1和HDAC2特异性结合,并抑制了它们的酶活性,从而阻止了从组蛋白尾巴中赖氨酸残基上除去乙酰基。 SphK2与阻遏物复合物中的HDAC1和HDAC2相关,并选择性富集在编码细胞周期蛋白依赖性激酶抑制剂p21或转录调节因子c-fos的基因的启动子上,在那里它增强了局部组蛋白H3的乙酰化和转录作用。因此,HDACs是SIP的直接细胞内靶标,并将核SIP与基因表达的表观遗传调控联系起来。

著录项

  • 来源
    《Science》 |2009年第5945期|1254-1257|共4页
  • 作者单位

    Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA;

    Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA;

    Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA;

    Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA;

    Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA;

    Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA;

    The Wistar Institute and Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104, USA State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P. R. China;

    The Wistar Institute and Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104, USA;

    Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA;

    National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA;

    Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号